182 related articles for article (PubMed ID: 38146007)
1. Comparative study on genomic and epigenomic profiles of retinoblastoma or tuberous sclerosis complex via nanopore sequencing and a joint screening framework.
Wang J; Zhang C; Zhang L; Yao HJ; Liu X; Shi Y; Zhao J; Bo X; Chen H; Li L
Cancer Gene Ther; 2024 Mar; 31(3):439-453. PubMed ID: 38146007
[TBL] [Abstract][Full Text] [Related]
2. Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism.
Song WP; Zheng S; Yao HJ; Zhou XF; Li R; Zhang CY; Zhao JY; Wang LW; Shao RG; Li L
BMC Ophthalmol; 2020 Mar; 20(1):92. PubMed ID: 32143590
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of germline
Rojanaporn D; Boontawon T; Chareonsirisuthigul T; Thanapanpanich O; Attaseth T; Saengwimol D; Anurathapan U; Sujirakul T; Kaewkhaw R; Hongeng S
Mol Vis; 2018; 24():778-788. PubMed ID: 30636860
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics analysis of multi-omics data identifying molecular biomarker candidates and epigenetically regulatory targets associated with retinoblastoma.
Zeng Y; He T; Liu J; Li Z; Xie F; Chen C; Xing Y
Medicine (Baltimore); 2020 Nov; 99(47):e23314. PubMed ID: 33217867
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive visualization of retinoblastoma growth and metastasis via bioluminescence imaging.
Ji X; Cheng L; Wei F; Li H; Wang M; Tian Y; Chen X; Wang Y; Wolf F; Li C; Huang Q
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5544-51. PubMed ID: 19608529
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the therapeutic effects of lobaplatin and carboplatin on retinoblastoma in vitro and in vivo.
Zhou Z; Jiang H; Xia J; Zhang J
Int J Oncol; 2020 Sep; 57(3):697-706. PubMed ID: 32582992
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA‑153‑3p suppresses retinoblastoma cell growth and invasion via targeting the IGF1R/Raf/MEK and IGF1R/PI3K/AKT signaling pathways.
Guo L; Bai Y; Ni T; Li Y; Cao R; Ji S; Li S
Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34036380
[TBL] [Abstract][Full Text] [Related]
8. Dissecting the Transcriptional and Chromatin Accessibility Heterogeneity of Proliferating Cone Precursors in Human Retinoblastoma Tumors by Single Cell Sequencing-Opening Pathways to New Therapeutic Strategies?
Collin J; Queen R; Zerti D; Steel DH; Bowen C; Parulekar M; Lako M
Invest Ophthalmol Vis Sci; 2021 May; 62(6):18. PubMed ID: 34003213
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous Copy Number Alteration and Single-Nucleotide Variation Analysis in Matched Aqueous Humor and Tumor Samples in Children with Retinoblastoma.
Schmidt MJ; Prabakar RK; Pike S; Yellapantula V; Peng CC; Kuhn P; Hicks J; Xu L; Berry JL
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239954
[TBL] [Abstract][Full Text] [Related]
10. The apoptotic and anti-proliferative effect of Lysyl oxidase propeptide in Y79 human retinoblastoma cells.
Nagaraj NR; Natarajan SK; Karunakaran C
Mol Vis; 2023; 29():125-139. PubMed ID: 38222455
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of sodium iodide symporter (NIS) protein expression by an innate immunity component: Promising potential for targeting radiosensitive retinoblastoma.
Samuel J; Singh N; Kanwar JR; Krishnakumar S; Kanwar RK
Exp Eye Res; 2015 Oct; 139():108-14. PubMed ID: 26213306
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-129-5p suppresses proliferation, migration and invasion of retinoblastoma cells through PI3K/AKT signaling pathway by targeting PAX6.
Liu Y; Liang G; Wang H; Liu Z
Pathol Res Pract; 2019 Dec; 215(12):152641. PubMed ID: 31727502
[TBL] [Abstract][Full Text] [Related]
13. Alterations in the RB1 gene in Pakistani patients with retinoblastoma using direct sequencing analysis.
Kalsoom S; Wasim M; Afzal S; Shahzad MS; Ramzan S; Awan AR; Anjum AA; Ramzan K
Mol Vis; 2015; 21():1085-92. PubMed ID: 26396485
[TBL] [Abstract][Full Text] [Related]
14. Single-cell transcriptomics enable the characterization of local extension in retinoblastoma.
Liu Y; Hu W; Xie Y; Tang J; Ma H; Li J; Nie J; Wang Y; Gao Y; Cheng C; Li C; Ma Y; Su S; Zhang Z; Bao Y; Ren Y; Wang X; Sun F; Li S; Lu R
Commun Biol; 2024 Jan; 7(1):11. PubMed ID: 38172218
[TBL] [Abstract][Full Text] [Related]
15. Global gene deregulations in FASN silenced retinoblastoma cancer cells: molecular and clinico-pathological correlations.
Sangeetha M; Deepa PR; Rishi P; Khetan V; Krishnakumar S
J Cell Biochem; 2015 Nov; 116(11):2676-94. PubMed ID: 25958981
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of miR-204-3p Driven by the Viability and Motility of Retinoblastoma via Wnt/β-catenin Pathway In Vitro and In Vivo.
Sun QX; Wang RR; Liu N; Liu C
Pathol Oncol Res; 2020 Jul; 26(3):1549-1558. PubMed ID: 31482398
[TBL] [Abstract][Full Text] [Related]
17. MiR-361-5p inhibits cell proliferation and induces cell apoptosis in retinoblastoma by negatively regulating CLDN8.
Liu B; Lu B; Wang X; Jiang H; Kuang W
Childs Nerv Syst; 2019 Aug; 35(8):1303-1311. PubMed ID: 31161266
[TBL] [Abstract][Full Text] [Related]
18. miRNA signature identification of retinoblastoma and the correlations between differentially expressed miRNAs during retinoblastoma progression.
Yang Y; Mei Q
Mol Vis; 2015; 21():1307-17. PubMed ID: 26730174
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of adenomatosis polyposis coli-2 and its tumor suppressor role in retinoblastoma.
Beta M; Chitipothu S; Khetan V; Biswas J; Krishnakumar S
Curr Eye Res; 2015 Jul; 40(7):719-28. PubMed ID: 25207834
[TBL] [Abstract][Full Text] [Related]
20. Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids.
Srimongkol A; Laosillapacharoen N; Saengwimol D; Chaitankar V; Rojanaporn D; Thanomchard T; Borwornpinyo S; Hongeng S; Kaewkhaw R
J Exp Clin Cancer Res; 2023 Feb; 42(1):39. PubMed ID: 36726110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
